| Product Information |
|
| Registration Number |
DR-XY47322
|
| Generic Name |
Olopatadine (as hydrochloride) + Mometasone furoate
(as monohydrate)
|
| Brand Name |
Ryaltris
|
| Dosage Strength |
665 mcg/25 mcg per actuation
|
| Dosage Form |
Nasal Suspension
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
White opaque round HDPE bottle containing 240 actuations with a crimped nasal spray pump fitted into a white actuator and purple HDPE cap (Box of 1's) White opaque round HDPE bottle containing 120 actuations with a crimped nasal spray pump fitted into a white actuator and purple HDPE cap (Box of 1's) White opaque round HDPE bottle containing 56 actuations with a crimped nasal spray pump fitted into a white actuator and purple HDPE cap (Box of 1's) [Physician's Sample)
|
| Manufacturer |
Glenmark Pharmaceuticals Ltd.
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Glenmark Philippines, Inc.
|
| Distributor |
Glenmark Philippines, Inc.
|
| Application Type |
-
|
| Issuance Date |
13 July 2021
|
| Expiry Date |
13 July 2026
|